PATENT CLAIM ANALYSIS

Application Number: 15936811
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "352000"]

Abstract:
The present disclosure relates generally to compounds and methods for inhibiting the enzymatic activity of lysine demethylase 4 (KDM4) and treating cancer. Provided herein are substituted pyridine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibiting lysine demethylase 4. Furthermore, the subject compounds and compositions are useful for the treatment of breast cancer and the like.

Claim (Index 8):
The compound of  claim 1 , wherein X is CH 2  and R 6  is N(R 1 )(R 2 ), in which R 1  is methyl, and R 2  is phenyl or pyridinyl.

Metadata:
- Claim Count in Document: 68.0
- Percentile: 90.0
- Lexical Diversity: 1.73171
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15792570', '15402100', '14443602', '13933609', '15475899']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7743600131901421
- 35 USC 102 Novelty (BERT): 0.510834296508764
- Combined Prediction Score: 0.7480074415220044
- Mean Citation Score: 256.860694
- Max Citation Score: 280.05762000000004
- Similarity Product: 202.5477263005793

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test